FOTIVDA Trademark

Trademark Overview

On Monday, March 30, 2015, a trademark application was filed for FOTIVDA with the United States Patent and Trademark Office. The USPTO has given the FOTIVDA trademark a serial number of 86580973. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Tuesday, September 27, 2022. This trademark is owned by AVEO Pharmaceuticals, Inc.. The FOTIVDA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cancer
fotivda

General Information

Serial Number86580973
Word MarkFOTIVDA
Filing DateMonday, March 30, 2015
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateTuesday, September 27, 2022
Registration Number4984746
Registration DateTuesday, June 21, 2016
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 25, 2015

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, April 8, 2015
Primary Code005
First Use Anywhere DateWednesday, March 9, 2016
First Use In Commerce DateWednesday, March 9, 2016

Trademark Owner History

Party NameAVEO Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBoston, MA 02108
Party NameAVEO Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142
Party NameAVEO Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events

Event DateEvent Description
Friday, June 30, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, June 30, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, June 30, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, June 30, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, June 30, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, September 27, 2022NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Tuesday, September 27, 2022REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, September 27, 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, March 30, 2022TEAS SECTION 8 & 15 RECEIVED
Monday, June 21, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, June 21, 2016REGISTERED-PRINCIPAL REGISTER
Tuesday, May 17, 2016NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, May 16, 2016ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Sunday, April 24, 2016STATEMENT OF USE PROCESSING COMPLETE
Tuesday, March 15, 2016USE AMENDMENT FILED
Wednesday, April 20, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, March 15, 2016TEAS STATEMENT OF USE RECEIVED
Tuesday, October 20, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 25, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 25, 2015PUBLISHED FOR OPPOSITION
Wednesday, August 5, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 21, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, July 20, 2015ASSIGNED TO LIE
Monday, July 6, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, July 6, 2015EXAMINER'S AMENDMENT ENTERED
Monday, July 6, 2015NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, July 6, 2015EXAMINERS AMENDMENT E-MAILED
Monday, July 6, 2015EXAMINERS AMENDMENT -WRITTEN
Monday, July 6, 2015ASSIGNED TO EXAMINER
Friday, May 29, 2015APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, May 29, 2015TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, April 8, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, April 2, 2015NEW APPLICATION ENTERED

Related Keywords

fotivda cancer treatment preparations pharmaceutical